Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020Angela Rose, Esther Kissling, Hanne‐Dorthe Emborg et al.|Eurosurveillance|2020Cited by 66
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Esther Kissling, Iván Martínez‐Baz, Naoma William et al.|Eurosurveillance|2021Cited by 55
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024Marine Maurel, Jennifer Howard, Esther Kissling et al.|Eurosurveillance|2024Cited by 50
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021Esther Kissling, Mariëtte Hooiveld, Iván Martínez‐Baz et al.|Eurosurveillance|2022Cited by 27
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025Angela Rose, Héloïse Lucaccioni, Kimberly Marsh et al.|Eurosurveillance|2025Cited by 24